BICYCLE THERAPEUTICS PLC
Developing novel bicyclic peptide medicines to precisely target hard-to-treat cancers.
BCYC | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines referred to as Bicycles®. These are synthetic, bicyclic peptides that form a proprietary therapeutic modality designed to combine the targeting precision of biologics with the tissue penetration of small molecules. The company's primary focus is on developing precision-guided therapeutics to treat solid tumors and other hard-to-target cancers. Beyond oncology, Bicycle Therapeutics engages in collaborations with pharmaceutical and academic partners to explore the application of its technology across a range of other therapeutic areas with unaddressed medical needs, including anti-infectives, cardiovascular diseases, and neurology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BICYCLE THERAPEUTICS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BICYCLE THERAPEUTICS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BICYCLE THERAPEUTICS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
